Melissa Murray

Okay.

hard to make that as a specific injury to Louisiana specifically.

You know, there's also a discussion of the whole question of the safety of mifepristone.

And they note that there are two people in Louisiana who suffered ill effects from the use of mifepristone, but they also say that, you know,

Over thousands of women have been using Mifepristone since Roe versus Wade fell in Dobbs.

So, I mean, make that make sense.

Thousands of women are using it.

Two women experience ill effects.

Therefore, it's a safety concern.

And that's one of the predicates under which they're bringing this lawsuit.

So I don't buy their claims of injury.

I don't know that the court will be as skeptical this time of those claims as they were when this case first came or a case like this came before the court.

Again, when FDA versus the Alliance for Hippocratic Medicine was before the court, it was right before a really consequential election.

It was just after the Supreme Court overruled Roe versus Wade and Dobbs.

I think the court knew that the...

galvanization of abortion fervor was not great for the court, also not great for the Republican Party.

I don't know if they're thinking that the same kinds of popular conditions exist right now.

The abortion question for a lot of people may have fallen to the wayside right now, just because the administration hasn't done anything explicit or obvious as an overture toward abortion rights.

People are worried about other things, the economy, the war in Iran, on and on and on.

This might actually be a moment where the court is like, you know, nothing to see here.